XML 49 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information (Tables)
 9 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Disaggregation of Revenue [Table Text Block]
The following tables present revenue for the two reportable segments and disaggregated revenue within the remaining operating segments, included in Other, and Corporate:
Three Months Ended March 31,
(in millions)20252024
Pharmaceutical and Specialty Solutions$50,433 $50,622 
Global Medical Products and Distribution3,160 3,113 
Nuclear and Precision Health Solutions403 352 
at-Home Solutions
817 730 
OptiFreight® Logistics
84 72 
Other
1,304 1,154 
Total segment revenue54,897 54,889 
Corporate (1)
(19)(21)
Total revenue$54,878 $54,868 
Nine Months Ended March 31,
(in millions)20252024
Pharmaceutical and Specialty Solutions$149,272 $154,412 
Global Medical Products and Distribution9,437 9,272 
Nuclear and Precision Health Solutions1,148 1,006 
at-Home Solutions
2,391 2,136 
OptiFreight® Logistics
234 198 
Other
3,773 3,340 
Total segment revenue162,482 167,024 
Corporate (1)
(63)(64)
Total revenue$162,419 $166,960 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following tables present revenue by geographic area:
Three Months Ended March 31,
(in millions)20252024
United States$54,498 $54,464 
International399 425 
 Total segment revenue54,897 54,889 
Corporate (1)(19)(21)
Total revenue$54,878 $54,868 
Nine Months Ended March 31,
(in millions)20252024
United States$161,247 $165,783 
International1,235 1,241 
Total segment revenue162,482 167,024 
Corporate (1)(63)(64)
Total revenue$162,419 $166,960 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following tables present segment profit for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
Three Months Ended March 31,
(in millions)20252024
Pharmaceutical and Specialty Solutions
$662 $582 
Global Medical Products and Distribution
39 22 
Other (1)134 110 
Total segment profit835 714 
Corporate(105)(345)
Total operating earnings
$730 $369 

Nine Months Ended March 31,
(in millions)20252024
Pharmaceutical and Specialty Solutions
$1,723 $1,533 
Global Medical Products and Distribution
65 45 
Other (1)356 312 
Total segment profit2,144 1,890 
Corporate(297)(1,048)
Total operating earnings
$1,847 $842 
(1)Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight® Logistics.
Assets by Reportable Segment
The following table presents total assets for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
(in millions)March 31,
2025		June 30,
2024
Pharmaceutical and Specialty Solutions
$35,734 $29,149 
Global Medical Products and Distribution
7,201 7,047 
Other (1)
2,726 2,606 
Corporate 4,210 6,319 
Total assets$49,871 $45,121 
(1)Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight® Logistics.